Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor Stem Cells and Recipient Tregs in Living Donor Kidney Transplantation
NCT03943238Phase 1Recruiting
- Sponsor
- Stanford University
- Start
- Feb 2020
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of recipient regulatory T cells in kidney transplant rejection, sponsored by Stanford University. Primary endpoints: Count of participants with sustained mixed chimerism of >25% at 18 months and Count of participants able to withdraw from immunosuppressive drugs without evidence of rejection at 18 months. Started Feb 2020; status: recruiting.
02
Drugs
recipient regulatory T cells
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03943238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943238.